FDA Inspection
Hangzhou Minsheng Binjiang Pharmaceutical Co., Ltd.Hangzhou Minsheng Binjiang Pharmaceutical Co., Ltd. – FDA Inspection, Jul 29, 2016
Record Details
This FDA Inspection record concerns Hangzhou Minsheng Binjiang Pharmaceutical Co., Ltd., with an inspection on July 29, 2016, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- July 29, 2016
- Product Type
- Drugs
View Company Profile
ID · 97923d47-e3d6-4e95-ab1f-fb4ed076a382
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 990181
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Hangzhou Minsheng Binjiang Pharmaceutical Co., Ltd.
6| Date | Classification | Office | Project area |
|---|---|---|---|
| March 7, 2025 | Not classified | Office of Inspections and Investigations | |
| September 13, 2019 | Not classified | Office of Inspections and Investigations | |
| October 18, 2018 | Not classified | Office of Inspections and Investigations | |
| May 11, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 25, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Hangzhou Minsheng Binjiang Pharmaceutical Co., Ltd.
- FDA Inspection 1265022 - 2025-03-07
- FDA Inspection 1107819 - 2019-09-13
- FDA Inspection 1070378 - 2018-10-18
- FDA Inspection 1053977 - 2018-05-11
- FDA Inspection 879374 - 2014-04-25
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.